Goblet Study in Hamburg Germany repost
Roche, Oncolytics, AIO Partner to Study Virus-Based Treatment Combinations for GI Cancers --------------------------------------- "Under the terms of its latest collaboration with Roche, the drug giant will provide atezolizumab to Oncolytics for use in the pelareorep clinical development program. "Despite the great commercial success of checkpoint inhibitors, as many as four in five patients do not respond to these therapies in most GI malignancies, often due to an immunosuppressive tumor microenvironment," Dirk Arnold, director of the Asklepios Tumor Center in Hamburg and a principal investigator of the GOBLET study, said in a statement. "We believe that pelareorep treatment may substantially increase the proportion of patients who are eligible for, and respond to, checkpoint inhibitor therapy" ----------------------------------------------- Asklepios Klinik Barmbek, Germany:The Asklepios Group is the biggest private operator of hospitals in the entire European continent, but the Hamburg centre is regarded as the crown jewel. This is a general hospital, but it ranks among the best in matters of cutting edge innovation and medical technology. Companies release drugs and equipment in the Klinik before they are made available to the rest of the world, and the centre boasts of excellent nursing and rehabilitation facilities. The Asklepios Klinik boasts of the worlds best known medical laboratory, and is well known ------------------------------------------ This Hamburg clinic is rated #2 in the world just behind John Hopkins center according to an internet search. ----------------------------------------